IVZ
48
2
C
60
2
HBAN
56
2
TRV
56
3
WEC
55
2
D
45
5
PEG
67
5
EXC
56
2
FE
52
3
DTE
54
4
PVH
57
5
PPL
59
5
TROW
51
3
FLS
75
2
AMZN
55
-3
AVY
50
2
KO
44
2
MCD
50
-2
FMC
33
2
GT
56
2
IVZ
48
2
C
60
2
HBAN
56
2
TRV
56
3
WEC
55
2
D
45
5
PEG
67
5
EXC
56
2
FE
52
3
DTE
54
4
PVH
57
5
PPL
59
5
TROW
51
3
FLS
75
2
AMZN
55
-3
AVY
50
2
KO
44
2
MCD
50
-2
FMC
33
2
GT
56
2
Financhill
Back

BioLine Rx Vs. Can Fite Biofarma Industry Stock Comparison

Sell
32

BLRX
BioLine Rx

Last Price:
0.33
Seasonality Move:
-0.3%
Sell
42

CANF
Can Fite Biofarma

Last Price:
2.00
Seasonality Move:
-4.74%
Sell
32
BioLine Rx (BLRX) is a Sell

Is BioLine Rx a Buy, Sell or Hold?

  • The current BioLine Rx [BLRX] share price is $0.32. The Score for BLRX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • BLRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $1.97. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BLRX Stock Price Chart

What is BioLine Rx's stock price today?

  • The BioLine Rx share price today is $0.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BLRX is experiencing selling pressure, which indicates risk of future bearish movement.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $1.97
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.

BLRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 32.96 Sell
Chaikin Money Flow: -9838520 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.4 - 0.48) Sell
Bollinger Bands (100): (0.47 - 0.73) Sell

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 36.2 Sell
Chaikin Money Flow: -53828 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.97 - 2.55) Sell
Bollinger Bands (100): (1.98 - 3.06) Sell

BLRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.46 Sell
20-day SMA: 0.44 Sell
50-day SMA: 0.5 Sell
200-day SMA: 0.73 Sell
8-day EMA: 0.45 Sell
20-day EMA: 0.46 Sell
50-day EMA: 0.5 Sell
200-day EMA: 0.74 Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.01 Sell
20-day SMA: 2.14 Sell
50-day SMA: 2.22 Sell
200-day SMA: 2.4 Sell
8-day EMA: 2.02 Sell
20-day EMA: 2.13 Sell
50-day EMA: 2.25 Sell
200-day EMA: 2.46 Sell

BioLine Rx Earnings Growth & BLRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and a decrease next year of $0.10 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.

BioLine Rx Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):